SEO URLwww.firestrike.ai/deals/repare-therapeutics-xenotherapeutics-acquisition-2026-2
acquisitionAnnounced · Jan 29, 2026BiotechnologySource · CredibleArticle · Factual
XenoTherapeutics acquires Repare Therapeutics
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
—
Target
Repare Therapeutics
NASDAQ: RPTX · Montreal, Quebec
Acquirer
XenoTherapeutics
Full Acquisition
Status
Pending
XenoTherapeutics agreed to acquire Repare Therapeutics. Reported deal value: Undisclosed. Status: Pending. Sector: Biotechnology. Target headquarters context: Montreal, Quebec, Canada.
This page summarizes publicly available information about the transaction as of 2026-01-29. Figures and status may change as filings and press coverage update.
Repare Therapeutics Inc. announced today the completion of the previously announced acquisition of all of the issued and outstanding common shares of the Company by Xeno Therapeutics , Inc. and Xeno Acquisition Corp . a non-profit biotechnology company, by way of a statutory plan of arrangement
Deal timeline
Announced
Jan 29, 2026 · biospace.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Biotechnology. Figures and status may change as sources update.
Sources: biospace.com · Primary article · FireStrike proprietary index